Background: The goal of the present study is to evaluate the efficacy and safety of Bailing capsules, which is a traditional Chinese drug that can improve lung functionality when used to treat chronic obstructive pulmonary disease (COPD) patients.
Methods: A comprehensive search will be performed on the following primary electronic databases: PubMed, EMBASE, Cochrane Library, Chinese National Knowledge Infrastructure, and WanFang database. A search of secondary sources includes reference lists of included studies. Two pairs of review authors will screen and scrutinize selected articles. This study will analyze continuous data as mean differences and dichotomous data as odds ratios, both with 95% confidence intervals. A sensitivity analysis will also be conducted to evaluate the stableness of the outcomes. RevMan 5.3 software was adopted to accomplish all the statistical analysis.
Results: The results obtained in this research shall be published in a peer-reviewed journal.
Conclusion: Based on the interpretations of the results, useful conclusions will be presented. These conclusions will offer additional insights with useful evidence to assess whether it is viable to use Bailing capsules as an effective and safety treatment option for COPD.
Ethics And Dissemination: The present work does not involve any humans or animals; therefore, ethical approval is not needed.
Systematic Review Registration: March 26, 2021.osf.io/kvgbu. (https://osf.io/kvgbu/).
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238341 | PMC |
| http://dx.doi.org/10.1097/MD.0000000000025672 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Effects of Bailing capsules combined with levothyroxine sodium on autoimmune thyroiditis.
Medicine (Baltimore)
November 2024
Department of Endocrinology, Shijiazhuang People's Hospital, Shijiazhuang, China.
To explore the clinical effects and adverse reactions of Bailing capsules combined with levothyroxine sodium for autoimmune thyroiditis, 70 patients with autoimmune thyroiditis were retrospectively enrolled and divided into the Bailing treatment group and the control, both consisting of 35 patients. The control group was treated with levothyroxine sodium alone, and the treatment group with Bailing capsules combined with levothyroxine sodium. The clinical efficacy, thyroid function indicators, antibodies and inflammatory indicators, and adverse drug reactions were analyzed.
View Article and Find Full Text PDFTherapeutic efficacy and pharmacological mechanism of Bailing capsule on chronic obstructive pulmonary disease: a meta-analysis and network pharmacology.
Pharm Biol
December 2024
Department of Respiratory and Critical Care Medicine, Hubei Province Clinical Research Center for Major Respiratory Diseases, Key Laboratory of Respiratory Diseases of National Health Commission, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Context: Bailing capsule, derived from (Berk.) Sacc. (Clavicipitaceae), has shown potential in the treatment of chronic obstructive pulmonary disease (COPD), a prevalent respiratory disorder.
View Article and Find Full Text PDFCordyceps protein alleviates renal injury by inhibiting T cell infiltration and Th1 cell differentiation in lupus nephritis mice.
Int Immunopharmacol
September 2024
College of Medical Technology, Chengdu University of Traditional Chinese Medicine, Chengdu, PR China; Chongqing Key Laboratory of Sichuan-Chongqing Co-construction for Diagnosis and Treatment of Infectious Diseases Integrated Traditional Chinese and Western Medicine, Chengdu, PR China; State Key Laboratory of Southwestern Chinese Medicine Resources, College of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, PR China. Electronic address:
Article Synopsis
- T cell infiltration and differentiation play a crucial role in lupus nephritis (LN), which is a severe kidney condition often associated with lupus, and earlier studies indicated that cordyceps (WCP) may help protect the kidneys and reduce fibrosis.
- This research aimed to explore how WCP affects the immune system in LN and how it works, using various laboratory techniques on lupus-prone mice over an 8-week treatment period.
- Results showed that WCP significantly improved kidney health by lowering urinary proteins and harmful antibodies, enhancing kidney structure, and decreasing harmful T cell activity, suggesting that WCP could be a beneficial treatment for managing lupus nephritis.
Study on chemical profiling of bailing capsule and its potential mechanism against thyroiditis based on network pharmacology with molecular docking strategy.
Biomed Chromatogr
September 2024
Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China.
Article Synopsis
- Bailing capsule (BLC) shows potential for treating thyroiditis by modulating the autoimmune system, with this study focusing on its chemical profile and therapeutic mechanisms using network pharmacology and molecular docking methods.
- The analysis identified 58 compounds in BLC, primarily nucleosides and amino acids, and highlighted 16 active components linked to key targets like AKT1 and MAPK3, which play roles in thyroid hormone regulation and inflammatory immune responses.
- Molecular docking confirmed that compounds such as adenosine and guanosine strongly bind to targets associated with the development of thyroiditis, providing insights for further research on BLC's therapeutic mechanisms.
preparations combined with the renin-angiotensin system inhibitor for diabetic kidney disease treatment: an umbrella review of systematic reviews and network meta-analysis.
Front Pharmacol
April 2024
Hubei Key Laboratory of Theory and Application Research of Liver and Kidney in Traditional Chinese Medicine, Affiliated Hospital of Hubei University of Chinese Medicine, Hubei Provincial Hospital of Traditional Chinese Medicine, Wuhan, China.
Aims: This study aimed to synthesize the evidence of the comparative effectiveness and safety of () preparations combined with renin-angiotensin system inhibitors (RASi) for diabetic kidney disease (DKD).
Methods: Eight databases were searched from their inception to May 2023. Systematic reviews (SRs) of preparations combined with RASi for DKD were identified.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!